… of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 …

K Reich, KA Papp, A Blauvelt, RG Langley… - The Lancet, 2021 - thelancet.com
… ) were significantly more efficacious in reaching an improvement of 90% or more in Psoriasis
Area and Severity Index score than the anti-IL-12/23 biologic ustekinumab and three anti-…

Adverse childhood experiences and adult obesity: a systematic review of plausible mechanisms and meta-analysis of cross-sectional studies

DA Wiss, TD Brewerton - Physiology & Behavior, 2020 - Elsevier
… Our results found a 46% increase in the odds of adult obesity following exposure to multiple
ACEs. Based on our qualitative synthesis and review of the most recent relevant literature, …

… everolimus in patients with advanced renal cell carcinoma: updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

RJ Motzer, B Escudier, S George, HJ Hammers… - Cancer, 2020 - Wiley Online Library
… common organ classes of treatment-related select AEs over time, we found that the incidence
of most events peaked during the initial 7 months of therapy, after which the incidence …

The influence of music tuned to 440 Hz & 432 Hz on the perceived arousal

M Kopka - Musik & Marken, 2022 - Springer
The aim of this article is to investigate whether music tuned to A4= 432 Hz leads to less
perceived arousal than music tuned to A4= 440 Hz. To answer this question, an experiment with …

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label …

ET Overton, G Richmond, G Rizzardini, H Jaeger… - The Lancet, 2020 - thelancet.com
… , most notably the phase 3 ATLAS and FLAIR studies showing cabotegravir plus rilpivirine
… evaluation of cabotegravir plus rilpivirine long-acting at longer, potentially more convenient, …

Predictors of mortality in patients with COVID-19–a systematic review

E Mehraeen, A Karimi, A Barzegary, F Vahedi… - European journal of …, 2020 - Elsevier
Introduction In the current COVID-19 pandemic, disease diagnosis is essential for optimal
management and timely isolation of infected cases in order to prevent further spread. The aim …

Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial

EP Winer, O Lipatov, SA Im, A Goncalves… - The Lancet …, 2021 - thelancet.com
… PD-L1 combined positive score (CPS) of 10 or more, those with a CPS of 1 or more, and all
… only if shown in those with a CPS of one or more. The primary endpoint was analysed in the …

[HTML][HTML] Peer-to-peer trust management in intelligent transportation system: An Aumann's agreement theorem based approach

TR Ramesh, M Vijayaragavan, M Poongodi, M Hamdi… - ICT Express, 2022 - Elsevier
… The aim of this work is to establish the truth of consensus, to identify the malicious nodes
with no further delay, by considering the decision of each vehicle on finding the trust values. …

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma… - The Lancet, 2022 - thelancet.com
Background Oral pre-exposure prophylaxis has been introduced in more than 70 countries,
including many in sub-Saharan Africa, but women experience considerable barriers to daily …

[HTML][HTML] Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19

L Sun, F Song, N Shi, F Liu, S Li, P Li, W Zhang… - Journal of Clinical …, 2020 - Elsevier
… SVM model was further analyzed by comparing the survival analysis. Since only three death
… In the future work, we will collect and analyze more samples from the other regions to further